Kestra Advisory Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-5,161
| Closed | -$563K | – | 2221 |
|
2023
Q1 | $563K | Sell |
5,161
-26,802
| -84% | -$2.93M | 0.01% | 1215 |
|
2022
Q4 | $3.64M | Sell |
31,963
-34,654
| -52% | -$3.94M | 0.03% | 532 |
|
2022
Q3 | $4.12M | Buy |
66,617
+26,739
| +67% | +$1.65M | 0.04% | 430 |
|
2022
Q2 | $3.18M | Buy |
39,878
+7,252
| +22% | +$578K | 0.03% | 498 |
|
2022
Q1 | $3.43M | Buy |
32,626
+2,614
| +9% | +$275K | 0.04% | 487 |
|
2021
Q4 | $3.23M | Buy |
30,012
+6,595
| +28% | +$711K | 0.03% | 517 |
|
2021
Q3 | $2.57M | Buy |
23,417
+3,042
| +15% | +$333K | 0.03% | 612 |
|
2021
Q2 | $1.91M | Buy |
20,375
+3,919
| +24% | +$367K | 0.02% | 670 |
|
2021
Q1 | $1.52M | Sell |
16,456
-26,306
| -62% | -$2.42M | 0.02% | 693 |
|
2020
Q4 | $3.09M | Buy |
42,762
+31,235
| +271% | +$2.26M | 0.04% | 458 |
|
2020
Q3 | $895K | Buy |
+11,527
| New | +$895K | 0.02% | 664 |
|